Skip to content

Real-World Evidence in Patient-Reported Outcomes for Medical Cannabis (MC-RWE)

Anxiety | Epilepsy | Pain | Depression | Sleep

This prospective observational study aims to describe the effectiveness of MC on pain, epilepsy, sleep and /or anxiety/depression in a cohorts of patients authorized to use MC, using pre-defined, validated self assessment scales.

null

Participation Requirements

  • Sex:

    ALL

  • Eligible Ages:

    19 and up

Participation Criteria

Inclusion Criteria:

* Subjects (≥19 years of age) who are MC-naïve or -experienced with a medical authorization for MC provided by a prescribing health care practitioner and who have provided informed consent
* Primary therapeutic indications for MC use: pain, epilepsy, sleep, and/or anxiety/depression.
* Subjects agree to use verified products and refrain from using any other cannabis products, either medical or recreational, during the duration of the study

Exclusion Criteria:

* Concomitant use of illicit drugs
* Concomitant use of recreational cannabis

Study Location

Toronto General Hospital, UHN
Toronto General Hospital, UHN
Toronto, Ontario
Canada

Contact Study Team

Backup Contact

Sonal Thaker

[email protected]
416-340-4800
Primary Contact

Jo Carroll, RN

[email protected]
416-340-4800
Study Sponsored By
University Health Network, Toronto
Participants Required
More Information
Study ID: NCT04526093